The making of a disease: female sexual dysfunction
نویسندگان
چکیده
منابع مشابه
The making of a disease: female sexual dysfunction.
The corporate sponsored creation of a disease is not a new phenomenon, but the making of female sexual dysfunction is the freshest, clearest example we have. A cohort of researchers with close ties to drug companies are working with colleagues in the pharmaceutical industry to develop and define a new category of human illness at meetings heavily sponsored by companies racing to develop new dru...
متن کاملFemale sexual dysfunction
Graziottin A 2005a Sexual pain disorders in adolescents. In: Genazzani A (ed) Proceedings of the 12th World Congress of Human Reproduction, International Academy of Human Reproduction, Venice, 10–13. CIC Edizioni Internazionali, Roma, p 434–449 Graziottin A 2006 Why deny dyspareunia its sexual meaning? Archives of Sexual Behaviour 34(1):32–34 Graziottin A 2006 Breast cancer and its effects on w...
متن کاملEpidemiology of female sexual dysfunction.
OBJECTIVE To review the epidemiology and co-morbidity of female sexual dysfunction. METHOD The prevalence of each sexual dysfunction was evaluated by undertaking a Medline (1969-2008) literature review. The effect of concomitant diseases and drug therapies was also studied. RESULTS Describing the epidemiology of female sexual dysfunction is difficult due to the fact that it has not been stu...
متن کاملPrevalence of Female Sexual Dysfunction in Different Pregnancy Trimesters: A Systematic Review and Meta-Analysis
Abstract Introduction: Pregnancy is one of the most sensitive periods in a woman's life. Physical and psychological changes during pregnancy can significantly affect the couples' sexual relations. Healthy sexual desire during pregnancy is essential for the development of couples as parents. Objective: This meta-analysis study estimates the prevalence of sexual dysfunction overall and in diffe...
متن کاملFemale sexual dysfunction: a focus on flibanserin
Flibanserin is the first US Food and Drug Administration (FDA)-approved option for sexual dysfunction, specifically low sexual desire. Until recently, there were no FDA-approved medication options to assist the ~40% of women affected by female sexual dysfunction (FSD). Often, patients report feeling uncomfortable discussing sexual health, identifying a strong need for health care professionals ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2003
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.326.7390.658